# FUZE (NCT03834220)

> Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT03834220
- Phase: PHASE2
- Status: TERMINATED
- Sponsor: Debiopharm International SA
- Conditions: Solid Tumor
- Interventions: Debio 1347
- Enrollment: 63
- Primary outcome: Objective Response Rate (ORR) as Centrally Measured by Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) Criteria

## Indexed commentary on FUZE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- X threads: 3

## Order

Focused, $750, price fixed at order: https://www.erudio.com/contact?report=fuze-nct03834220